Lv1
28 积分 2024-04-22 加入
1860P Preliminary results of phase II study on HB0025 (a PD-L1/VEGF trap antibody fusion) with chemotherapy as first-line treatment for advanced non-small cell lung cancer (NSCLC)
19天前
已关闭
1255MO A phase II safety and efficacy study of PM8002/BNT327 in combination with chemotherapy in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
19天前
已完结
Abstract CT152: Preliminary results from a phase II trial evaluating the safety and efficacy of JS207, a bispecific antibody targeting PD-1 and VEGF, in combination with chemotherapy in patients with metastatic colorectal cancer
19天前
已完结
AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial
21天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
21天前
已完结
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads
1个月前
已关闭
Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI‐LUMA for the Treatment of Moderate‐To‐Severe Melasma in Chinese Patients: A Randomized, Single‐Center, Placebo‐Controlled Trial
1个月前
已完结
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency
1个月前
已完结
Encephalitis Induced by Immune Checkpoint Inhibitors
2个月前
已完结
Evaluating tertiary adrenal insufficiency in rheumatology patients on long‐term systemic glucocorticoid treatment
2个月前
已完结
皖公网安备34019202002308
